Table of Contents Introduction Non-Alcoholic Steatohepatitis (NASH) - Overview Non-Alcoholic Steatohepatitis (NASH) - Therapeutics Development Non-Alcoholic Steatohepatitis (NASH) - Therapeutics Assessment Non-Alcoholic Steatohepatitis (NASH) - Companies Involved in Therapeutics Development Non-Alcoholic Steatohepatitis (NASH) - Drug Profiles Non-Alcoholic Steatohepatitis (NASH) - Dormant Projects Non-Alcoholic Steatohepatitis (NASH) - Discontinued Products Non-Alcoholic Steatohepatitis (NASH) - Product Development Milestones Appendix

List of Tables Number of Products under Development for Non-Alcoholic Steatohepatitis (NASH), H1 2019 Number of Products under Development by Companies, H1 2019 Number of Products under Development by Universities/Institutes, H1 2019 Products under Development by Companies, H1 2019 Products under Development by Universities/Institutes, H1 2019 Number of Products by Stage and Target, H1 2019 Number of Products by Stage and Mechanism of Action, H1 2019 Number of Products by Stage and Route of Administration, H1 2019 Number of Products by Stage and Molecule Type, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by 3-V Biosciences Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by 89bio Ltd, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Abide Therapeutics Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by AdAlta Ltd, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Akcea Therapeutics Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Akero Therapeutics Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Albireo Pharma Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Aldeyra Therapeutics Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Allergan Plc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Allinky Biopharma SL, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Alteogen Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Angion Biomedica Corp, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Araim Pharmaceuticals Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Arcturus Therapeutics Ltd, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Ardelyx Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Ascletis Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Assembly Biosciences Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by AstraZeneca Plc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Betagenon AB, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by BioElectron Technology Corp, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Bird Rock Bio Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by BLR Bio LLC, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Boehringer Ingelheim GmbH, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Bristol-Myers Squibb Co, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Cadila Healthcare Ltd, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Can-Fite BioPharma Ltd, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Carmot Therapeutics Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Celgene Corp, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Cerenis Therapeutics Holding SA, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by ChemoCentryx Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by CJ HealthCare Corp, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by CohBar Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Coherus BioSciences Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by ConSynance Therapeutics Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by ContraVir Pharmaceuticals Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Corcept Therapeutics Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by CymaBay Therapeutics Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Daiichi Sankyo Co Ltd, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Debiopharm International SA, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Dicerna Pharmaceuticals Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Dimerix Bioscience Pty Ltd, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Dong-A Socio Holdings Co Ltd, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by DURECT Corp, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Eli Lilly and Co, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Enanta Pharmaceuticals Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Enyo Pharma SA, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Esperion Therapeutics Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Exicure Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Forma Therapeutics Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Galectin Therapeutics Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Galecto Biotech AB, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Galmed Pharmaceuticals Ltd, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Gemphire Therapeutics Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Genfit SA, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by GenKyoTex SA, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Gilead Sciences Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by GRI Bio Inc, H1 2019 Non-Alcoholic Steatohepatitis (NASH) - Pipeline by Guangdong Zhongsheng Pharmaceutical Co Ltd, H1 2019List of Figures Number of Products under Development for Non-Alcoholic Steatohepatitis (NASH), H1 2019 Number of Products under Development by Companies, H1 2019 Number of Products under Development by Universities/Institutes, H1 2019 Number of Products by Top 10 Targets, H1 2019 Number of Products by Stage and Top 10 Targets, H1 2019 Number of Products by Top 10 Mechanism of Actions, H1 2019 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019 Number of Products by Top 10 Routes of Administration, H1 2019 Number of Products by Stage and Top 10 Routes of Administration, H1 2019 Number of Products by Top 10 Molecule Types, H1 2019 Number of Products by Stage and Top 10 Molecule Types, H1 2019

3-V Biosciences Inc 89bio Ltd Abide Therapeutics Inc AdAlta Ltd Akcea Therapeutics Inc Akero Therapeutics Inc Albireo Pharma Inc Aldeyra Therapeutics Inc Allergan Plc Allinky Biopharma SL Alteogen Inc Angion Biomedica Corp Araim Pharmaceuticals Inc Arcturus Therapeutics Ltd Ardelyx Inc Ascletis Inc Assembly Biosciences Inc AstraZeneca Plc Betagenon AB BioElectron Technology Corp Bird Rock Bio Inc BLR Bio LLC Boehringer Ingelheim GmbH Bristol-Myers Squibb Co Cadila Healthcare Ltd Can-Fite BioPharma Ltd Carmot Therapeutics Inc Celgene Corp Cerenis Therapeutics Holding SA ChemoCentryx Inc CJ HealthCare Corp CohBar Inc Coherus BioSciences Inc ConSynance Therapeutics Inc ContraVir Pharmaceuticals Inc Corcept Therapeutics Inc CymaBay Therapeutics Inc Daiichi Sankyo Co Ltd Debiopharm International SA Dicerna Pharmaceuticals Inc Dimerix Bioscience Pty Ltd Dong-A Socio Holdings Co Ltd DURECT Corp Eli Lilly and Co Enanta Pharmaceuticals Inc Enyo Pharma SA Esperion Therapeutics Inc Exicure Inc Forma Therapeutics Inc Galectin Therapeutics Inc Galecto Biotech AB Galmed Pharmaceuticals Ltd Gemphire Therapeutics Inc Genfit SA GenKyoTex SA Gilead Sciences Inc GRI Bio Inc Guangdong Zhongsheng Pharmaceutical Co Ltd Hana Pharm Co Ltd Hanmi Pharmaceuticals Co Ltd HemoShear Therapeutics, LLC HotSpot Therapeutics Inc IB Pharmaceuticals Inc Immupharma Plc Immuron Ltd Indalo Therapeutics Inc Integral Molecular Inc Intercept Pharmaceuticals Inc Inventiva Inversago Pharma Inc Ionis Pharmaceuticals Inc Kowa Co Ltd Kyorin Pharmaceutical Co Ltd LG Chem Ltd LifeMax Laboratories Inc Lin Bioscience Inc Lipocine Inc Madrigal Pharmaceuticals Inc MallInckrodt Plc MedImmune LLC Merck & Co Inc Metabolys SAS Metacrine Inc Mina Therapeutics Ltd Mitsubishi Tanabe Pharma Corp Naia Ltd Nash Pharmaceuticals Inc NeuroVive Pharmaceutical AB NGM Biopharmaceuticals Inc Nippon Chemiphar Co Ltd Novartis AG Novo Nordisk AS Nuevolution AB NuSirt Biopharma Inc Oramed Pharmaceuticals Inc Pfizer Inc Phanes Therapeutics Inc Pharmaxis Ltd Phenex Pharmaceuticals AG Pliant Therapeutics Inc Poxel SA Promethera Biosciences SA ProMetic Life Sciences Inc Protalix BioTherapeutics Inc Redx Pharma Plc Regulus Therapeutics Inc reMYND NV Ritter Pharmaceuticals Inc Saje Pharma LLC Sancilio & Company Inc Sanofi ScandiCure AB Second Genome Inc Seres Therapeutics Inc SFA Therapeutics LLC Shenzhen HighTide Biopharmaceutical Ltd Sihuan Pharmaceutical Holdings Group Ltd Synlogic Inc T3D Therapeutics Inc TaiwanJ Pharmaceuticals Co Ltd Terns Pharmaceuticals Inc Tiziana Life Sciences Plc TRACON Pharmaceuticals Inc Vascular Biogenics Ltd Verlyx Pharma Inc Viking Therapeutics Inc Visionary Pharmaceuticals Inc Vivus Inc WAVE Life Sciences Ltd Yuhan Corp Zafgen Inc Zebra Discovery Ltd